Ginkgo Bioworks Holdings Inc Dossier
Outlook & Key Dates
Estimates, guidance, catalysts, and upcoming events
Analyst Estimates Learn more →
Analyst Coverage
2analysts covering
FY EPS (est.)
-$3.42next fiscal year
Monitoring Framework
Key Performance Indicators
Quarterly Revenue from Continuing Operations Quarterly19M
Annual Cash Burn Annually48MTarget: 125000000 to 150000000
Nebula Autonomous Lab Operational Racks Quarterly10,300.0%Target: Double the size of Nebula within 2026
Watch Items
- Monetization and commercial adoption of the capital-intensive Nebula autonomous lab platformTrigger: Failure to secure new external system sales or scale Cloud Lab/Datapoints contract research servicesAction: Re-evaluate capital allocation, slow down decommissioning of traditional lab benches, and adjust cash burn targets
- Restructuring execution and cash runway sustainabilityTrigger: Quarterly cash burn exceeding $50 million or cash runway dropping below 2 yearsAction: Implement further operational cost-cutting measures and optimize excess lease space costs
Research as of 19 Jun 2026